operator, Penna; Sales. XXXX our our today second you, by Global Thank call. and to President Financial of be welcome, quarter earnings Domenic Officer, Ross joined Venus Chief of Portaro, Della Concept's I'm and everyone, conference pleased to
sales cash agenda with flow provide with our second the then will which XXXX, our the an our more have reported revenue business year-over-year today's will excluding in subscription our focus revenues commercial remarks. U.S. release. company. The start quarter our I a customers X% systems X% me profile X% implemented Then operations our up initiatives revenue period. year-over-year, strategy, business in sales revenues from press with you overview of a the and in Let questions. overall procedure-related $XX.X of in our to was increased open Domenic revenue discontinued X% get and increase and of And period our GAAP what our let's to million, disposal brief during customers as QX We to cover quarterly and discussion and to we global performance for that started in to in-depth will QX, growth by revenue and review Total balance With results, we exited call year XXXX. your X% of prior full of a trends. prepared financial revenue growth and up driven total sheet second in the a of results year with mind, guidance enhance in year-over-year. will in our we the updated that start increased we of international streamline that overview VeroGrafter year-over-year quarter we review the
franchises strategy total our revenue discussed key calls. in we QX investor of by recent our Importantly, as we was commercial growth part driven the have prioritized in
fueled our on March. was adoption year-over-year in & ARTAS franchises program Bureau growth demand initial the XX% iX robotic excluding year-over-year posting our revenue, sales. system And in Grafters BlissMAX XX% increased strong in strong growth for launch sales Specifically, commercial QX, by our following quarter, system this continued
we team While for U.S. and were expectations. key see are growth drove significant market, sales in our key sales productivity our had U.S. turnover to a We material leadership lower franchise impact results. market products This during in demand continued in a on revenue U.S. in was this QX, which the issue force sales in unfortunately results below regrettable strong quarter. this disruption pleased in force our our market experienced total
QX. and this have very we aligned market issue team rebuilt said, our That are market U.S. sales in since sales the to with by in results rest strong of leadership consolidated address our the in sales key encouraged We values this and the U.S. strategy. the have core
pipeline. a our where of the very we had subscription results quarter. system disruption, in outside market strong validated the heading to year-over-year second delivered and The qualified into continues and growth team sales enthusiasm XX% build Our of
environment operating in ready future are in total significant that the for of growth us we entered the we experienced commercial to to strategy, of qualified QX, we as positioned The improving driving and product our and our right success. had right our have flow the and level confidence portfolio softer-than-expected have with capitalize belief pipeline well and enhancing revenue We cash improving in not extremely profitability business. conviction profile which commitment our change QX our did on
In fact, in world potential comprehensive we undertook and operate. which of review and of expectations the business our updated growth in profitability regions we a for our all
of to half product more a sustainable profitability. and strategic team recurring focused our revenue we are series [ph] our with benefits of lines, initiatives cash path our the realize implementing profile The of will XXXX. streamlining accelerate and on streams. to implemented, cash strategic our programs have and fall further profile sales we operations. These initiatives to With in commercial commercial developed and the key a messaging the to with enhance to meaningful strategy, two focused those already global expect We to in strategy flow of strategic we monitor more being on flow direct focused long-term second including business and are the targeted brackets- into our U.S. continue respect initiatives
to U.S. prioritizing potential address are are not highly continued in demand as flow maximize subscription Note, our contribute We strong our technology differentiated our and market. the cash that model. we shelving the industry-first cash the profitability should system sales we
certain this geographic products in offer going business differentiated to continue for forward. will certain We markets model
ensure more stricter disciplined however, company financial not specifically a are and macro exposed approach the over fluctuations to to qualifications will, results pricing to We global environment. the rate subscription model our forward, and total interest in credit bring going
mix targeting of subscription to XX% to be than system shift XX% sales We of half expect compared and XXXX first a year. the of more we cash the these second half commercial sales in in material are initiatives to systems and in the revenues our result a in
plan this team have the embrace strategic this, support fully to We our compensation initiative. we and aligned force to sales important expect
our justifies efforts improvement flow this in expected the area. half 'XX the on an impact the cash towards conversion for in While cash shift expectations in revenue our second total XXXX, has sales our of
respect series may that global Now redundant streamlining balance of our include international investing, over plan comprehensive closing on XXXX. efforts offices, review actions eliminating to our with of of operations operations, based reorganizing on of the and markets, we our a
Our growth operations coming in and unprofitable years cannot support international in this profitability objectives markets.
to and activities total XXXX. these modest results While in second are impact reduce a half on are XXXX, our represent expected expenses expenses year will annualized revenue the in operating our of our the in materially reduce it
direct footprint we recall, markets higher international in like our restructuring EMEA. Domenic may markets opportunity global interest including and resources you countries As America and smaller, XXXX, less in commercial these in our a North our you divesting on as additional reinvesting those entity flow implemented financial areas profitable our of on profitable additional a in initiatives, sustainably working as future. expense to detail support optimize are operating well where in of the profile becoming focus cash provide go-forward and key we will to
clearence highly contouring call XXX(k) clearances Before clearance the areas its on clinical an The body with early differentiated market of our workstation new customers. stronger provide size and and April, of new further have increase use product lipolysis the energy abdomen making an to Domenic, include wanted indication workstation ultimately This by efficiency the use I commercialization. and RF the flanks areas increasing we the even and output market an and for commercial to I and single expands to of progress in over and energy in offers the the announced the clinical results validation, BlissMAX new end for are new expanded a by maximum we for to turn revenue provide with XX%, you body which body physicians addition back our BlissMAX and been will of flexibility output. believe notable to increased during versatility has in initial to this strong the been utility of indications BlissMAX sales the development, treatments, In regulatory update more in the response non-invasive RF launch. contouring receipt we
to continue growth of U.S. the XXXX. U.S. of in strong sales contributions to the drive We total expect to Bliss and company in BlissMAX outside
to Finally, skin of and and We in our resurfacing submission. XX the progress proud platform for have and non-surgical with the during recent engaging we clinical of been excision continued our submission for regulatory the development, strategy indication months FDA advance applications. robotic-technology aesthetic medical March for made XXX(k) we Aime, the of have tissue announced the general our are in review
to extremely has clinicians, we different the differentiated process parallel has it predictability In skin new that clinical to Aime strategy a the true indications believe for changing innovation potential speed, market by been very for Aime The upgrade aesthetic customers. is me, also path It indication Aime and of made have and and introducing way the resurfacing, to platform, treatments to designed excision secure for for platform safety in excuse to prospects today. look the bringing support to medical - We the that the indications are available towards procedures important cost effective via to for the submitting forward specific continue progress the clinical any clinical tissue our from to are level of is bring numerous on aesthetics that the compelling, and device remember a and Aime this general face. for unique just technology. disruptive to we market performed products currently making a
wrinkles This our for enhance specific expand wrinkles. the patients treatment the growth using safety first announced enrolling of profile. clinical We pursuing study for patient investigation will will moderate in long-term submission and and are indications addressable of facial study market XX We XXX(k) clinical our study. treatment cheeks, April evaluating an our which IDE opportunity busy for treating to for severe are of sets further and [indiscernible] the to efficacy our treatments annual and Aime support
financial turn second me our discuss will a our Domenic financial Now Domenic? with of detailed XXXX that, quarter Penna over who and provide balance review condition our let call sheet, guidance. to results updated the Della and